Comparing the Effect of Intravitreal Bevacizumab in Diabetic Macular Edema with and without Epimacular Membranes
Publish Year: 1397
نوع سند: مقاله کنفرانسی
زبان: English
View: 521
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
IRAVOMED08_061
تاریخ نمایه سازی: 21 اردیبهشت 1397
Abstract:
Purpose: To compare the effect of intravitreal bevacizumab injection on central macular thickness in patients with clinically significant macular edema (CSME) with and without epiretinal membrane (ERM).Methods: In a prospective interventional comparative study, intravitreal bevacizumab injections were performed in patients with CSME and ERM. The anatomical and visual outcomes were compared in patients with and without ERM.Results: Fifty patients were included. There was no statistically significant reduction in central macular thickness (CMT) in the ERM group ( = 22 microns, P =0.07). CMT significantly decreased in the patients who did not have ERM ( = 57 microns, P =0.02). Patients with ERM had 0.09 Log MAR improvement in best corrected visual acuity (BCVA, P =0.001) in contrast to no significant change in BCVA of patients who did not have ERM (P =0.37).Conclusion: Intravitreal bevacizumab improved BCVA in patients who had CSME and ERM. However, in patients who had CSME without ERM, the reduction in CMT was not associated with any significant improvement in BCVA
Authors
Khalil Ghasemi Falavarjani
Eye Research Center and Department of Ophthalmology, Rassoul Akram Hospital, Iran University of Medical Sciences
Tafgeh Mohammadi
Eye Research Center and Department of Ophthalmology, Rassoul Akram Hospital, Iran University of Medical Sciences
Maryam Ashraf
Eye Research Center and Department of Ophthalmology, Rassoul Akram Hospital, Iran University of Medical Sciences
Mahmoud Motallebi
Eye Research Center and Department of Ophthalmology, Rassoul Akram Hospital, Iran University of Medical Sciences